Stryker Shares Outstanding 2010-2022 | SYK

Stryker shares outstanding history from 2010 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Stryker shares outstanding for the quarter ending March 31, 2022 were 0.383B, a 0.26% increase year-over-year.
  • Stryker 2021 shares outstanding were 0.382B, a 0.53% increase from 2020.
  • Stryker 2020 shares outstanding were 0.38B, a 0.11% increase from 2019.
  • Stryker 2019 shares outstanding were 0.38B, a 0.11% decline from 2018.
Stryker Annual Shares Outstanding
(Millions of Shares)
2021 382
2020 380
2019 380
2018 380
2017 380
2016 379
2015 381
2014 383
2013 382
2012 383
2011 390
2010 400
2009 399
Stryker Quarterly Shares Outstanding
(Millions of Shares)
2022-03-31 383
2021-12-31 382
2021-09-30 383
2021-06-30 382
2021-03-31 382
2020-12-31 380
2020-09-30 380
2020-06-30 376
2020-03-31 380
2019-12-31 380
2019-09-30 380
2019-06-30 380
2019-03-31 379
2018-12-31 380
2018-09-30 380
2018-06-30 380
2018-03-31 381
2017-12-31 380
2017-09-30 380
2017-06-30 380
2017-03-31 379
2016-12-31 379
2016-09-30 379
2016-06-30 379
2016-03-31 377
2015-12-31 381
2015-09-30 381
2015-06-30 381
2015-03-31 384
2014-12-31 383
2014-09-30 383
2014-06-30 383
2014-03-31 383
2013-12-31 382
2013-09-30 382
2013-06-30 381
2013-03-31 383
2012-12-31 383
2012-09-30 383
2012-06-30 383
2012-03-31 384
2011-12-31 390
2011-09-30 388
2011-06-30 392
2011-03-31 394
2010-12-31 400
2010-09-30 398
2010-06-30 399
2010-03-31 400
2009-12-31 399
2009-09-30 400
2009-06-30 399
2009-03-31 399
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $77.090B $17.108B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $192.989B 19.61
Medtronic (MDT) Ireland $122.590B 16.26
Boston Scientific (BSX) United States $54.338B 23.04
Baxter (BAX) United States $32.976B 17.28
ResMed (RMD) United States $31.557B 38.18
Zimmer Biomet Holdings (ZBH) United States $22.481B 14.76
Koninklijke Philips (PHG) Netherlands $19.219B 13.19
Bio-Rad Laboratories (BIO) United States $15.041B 32.62
Smith & Nephew SNATS (SNN) United Kingdom $12.201B 0.00
Envista Holdings (NVST) United States $6.365B 20.49
Perrigo (PRGO) Ireland $5.519B 21.82
Haemonetics (HAE) United States $3.453B 25.99
BellRing Brands (BRBR) United States $3.413B 24.30
Owens & Minor (OMI) United States $2.464B 9.07
Warby Parker (WRBY) United States $1.083B 0.00
Zevia PBC (ZVIA) United States $0.177B 0.00
Vapotherm (VAPO) United States $0.065B 0.00